Physician profile
Kyle Shaw
NPI 1710410899
$1,228.02
in general payments reported to CMS, 2019-2025
17 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.24 · 2022: $97.90 · 2023: $13.58 · 2024: $898 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $690 · Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $690.04 |
| Food and Beverage | $365.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $705.19 | 2022-2024 | Acell |
| Smith+Nephew, INC. | $108.15 | 2022-2025 | Collagenase Santyl, Grafix Pl |
| Eclipse Technology Solutions INC. | $70.72 | 2024 | |
| Misonix INC | $48.89 | 2021 | |
| Organogenesis INC. | $43.16 | 2024 | Apligraf |
| Orthofix Medical, INC. | $34.09 | 2024-2025 | Physio-Stim |
| Philips North America LLC | $31.50 | 2025 | Vest Therapy Und, Patient Interface Software |
| Ovik Health, LLC | $27.35 | 2024 | Coflex Tlc |
| Stryker Corporation | $25.35 | 2021 | |
| Depuy Synthes Sales INC. | $20.06 | 2022 | |
| Novo Nordisk INC | $19.52 | 2024 | Rybelsus, Ozempic |
| Ibsa Pharma INC. | $17.55 | 2025 | Flector, Licart, Tirosint |
| Paragon 28, INC. | $17.37 | 2022 | |
| Acera Surgical, INC. | $16.24 | 2022 | |
| Biotissue Holdings INC. | $15.73 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $13.58 | 2023 | Senza |
| Paratek Pharmaceuticals, INC. | $13.57 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.